Detalles de la búsqueda
1.
Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective observational study in daily clinical practice.
Br J Haematol
; 187(5): 615-626, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31394591
2.
Nilotinib after imatinib first-line: a real-life longitudinal cohort of patients with chronic myeloid leukaemia in chronic phase.
Br J Haematol
; 180(3): 356-364, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29265184
3.
Impact of ELN recommendations in the management of first-line treated chronic myeloid leukaemia patients: a French cross-sectional study.
Br J Haematol
; 174(1): 71-80, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27060881
4.
Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
Naunyn Schmiedebergs Arch Pharmacol
; 365(3): 242-52, 2002 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-11882920
5.
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes.
J Pharmacol Exp Ther
; 303(2): 815-22, 2002 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-12388668
6.
Persistence of the nitric oxide pathway in the aorta of hypercholesterolemic apolipoprotein-E-deficient mice.
J Vasc Res
; 40(2): 87-96, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12808344
Resultados
1 -
6
de 6
1
Próxima >
>>